
Isabel Aguilera
unknownFemale0.0Global Dominance: 0.00%
Isabel Aguilera is departing from the board of Oryzon Genomics, where she played a significant role in guiding the company through its recent advancements and developments in mental health treatments.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Isabel Aguilera is set to leave the Oryzon board.
Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | EmpresasEl País·
Spain· 2025-02-24








